BD, Medtronic and ARGON MEDICAL are dominating the Global Bone Marrow Biopsy Market in 2019

Global Bone Marrow Biopsy Market is expected to grow with the CAGR of 5.8% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access full Report @ https://www.databridgemarketresearch.com/reports/global-bone-marrow-biopsy-market

Global bone marrow biopsy market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global bone marrow biopsy market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This has helped companies to maximize the sales with enhanced product portfolio. For instance, in September 2018, BD arrived into divestiture of its soft tissue core needle biopsy line and Aspira product line to Merit Medical. This helped in expanding the direct sales and distribution across the globe.

BD is the dominating player in global bone marrow biopsy market. The other key players existing in the market includes Medtronic, ARGON MEDICAL, Teleflex Incorporated, Cardinal Health, Merit Medical Systems, Cook, MDL SRL., Zamar Care, SOMATEX Medical Technologies GmbH, Medical Devices Business Services, Inc. (A subsidiary of Johnson & Johnson Services, Inc.), BPB medica, STERYLAB S.r.l., Tsunami Medical Srl, Jorgensen Labs, weLLgo Medical Products GmbH, Hiprove, Shanghai Mekon Medical Devices Co., Ltd., Biomedical Srl, Egemen International among others.

BD:

BD headquartered in New Jersey, U.S. was incorporated in 1897. The company focuses on instruments used for the diagnosis of infectious diseases. They offer a variety of products such as direct testing products, environmental systems, prepared media products and others. The company deals in various business segments such as medical, life science and interventional among which interventional is the market focused segment. The products offered by the company lies in various categories such as anesthesia delivery, biosciences, bio surgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation home care, infection prevention, infusion therapy, interventional specialties and other variety of products. The market focused products lie under interventional specialities. The company is engaged in continuous development of bone marrow biopsy needles.   

For instance,

  • In September 2018, BD arrived into divestiture of its soft tissue core needle biopsy line and Aspira product line to Merit Medical. This has helped in expanding the direct sales and distribution across the globe.

The company has wide presence across U.S., Greater Asia and Europe. The company has various subsidiary companies named as Accuri Cytometers, Inc. (Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware) and B-D (Cambridge U.K.) Ltd. (U.K.) among others.

Medtronic:

Medtronic, headquartered in Dublin, Ireland was founded in 1949. The company focuses on contributing to human welfare by alleviating pain, restoring health, and extending life by offering products for diabetes, digestive & gastrointestinal and surgical navigation among others. The company has multiple business segments such as cardiac and vascular group, restorative therapies group, minimally invasive therapies group, surgical innovations, cardiac rhythm & heart failure, coronary & structural heart, brain therapies, diabetes group, spine, respiratory, gastrointestinal, & renal, aortic, peripheral & venous, specialty therapies, and pain therapies among which minimally, invasive therapies group is the market focused segment. The company is providing products under healthcare professionals and patients & caregivers. The market focused products lie under healthcare professionals’ product category. The company is engaged in continuous development of bone marrow biopsy market .

For instance,   

  • In April 2011, Medtronic launched a new bone marrow aspiration needle kit known as MARROWMAX and expanded its product portfolio in bone grafting. This has enhanced the product portfolio which helped in increasing the revenue of the company from the respective segment.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies namely, Titan Spine, Inc. (U.S), Given Imaging (Israel), Medtronic Japan Co., Ltd. (Japan), Aptus Endosystems (U.S.), superDimension, Ltd. (Israel) among others.

ARGON MEDICAL:  

ARGON MEDICAL Company is headquartered in Frisco, U.S. The company is focused on providing products such as fluid management systems, urology, vascular access, dialysis, drapes, bone marrow biopsy and others. The company is engaged in providing its products under various categories such as arterial lines, bone & bone marrow biopsy, dialysis, drainage, drapes & covers, endomyocardial biopsy, HSG catheters & prostate needles, guidewires, introducer sets & arterial needles, mammography, neonatal pediatric PICC & midline catheters, retrieval kit, soft tissue biopsy and thrombus management among which the market focused category is bone & bone marrow biopsy.

For instance,

  • In March 2013, ARGON MEDICAL along with Roundtable Healthcare Partners acquired the interventional products business of Angiotech Pharmaceutical, Inc. This acquisition has helped in widening of the segment product portfolio and increased revenue of the company in the market.

The company has wide presence across North America, Europe and Asia & Middle East & Africa.